Weight Loss Drug - Wegovy |ForumIAS

ForumIAS LATEST

1. 1. FRC 2027: SFG Residential program | accepting application for Tranche-2 Click Here to know more →
  2. CSAT Classes for Prelims 2027 by Rishi Bhargav sir starts 16 Nov. at 5 PM Click Here to know more →
  3. Prelims Sprint classes 2027: Starts 2nd Nov. at 4:30 PM | First class open to all. Click Here to know more →

News: Danish drugmaker Novo Nordisk has launched its weight loss drug Wegovy as a once-a-week injection in India.

About Weight Loss Drug – Wegovy

It is a prescription weight loss drug developed by Danish pharmaceutical company Novo Nordisk.
It contains semaglutide, a GLP-1 receptor agonist originally developed for type 2 diabetes but found to be highly effective for weight loss.
It is administered as a once-weekly injection using a convenient pen device (FlexiPen or FlexTouch).
The drug is approved by Central Drugs Standard Control Organisation, (CDSCO) in India strictly for obesity management and not for diabetes.

It is made of semaglutide, a GLP 1A receptor agonist, which mimics the naturally occurring hormone GLP-1, responsible for regulating blood sugar, reducing appetite and slowing down gastric emptying.
It makes a person feel fuller for longer and eat less.

Ozempic is used more for diabetes management. The main difference between the two is the dose.
Rybelsus is an oral pill for the same.
Mounjaro is made up of tirzepatide, which mimics the function of natural hormones GIP and GLP-1.
- It has a double effect, of increasing insulin secretion in response to food intake and improving glucose control and weight loss.